Insight
Life and Health Insurance M&A
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
Markets were mixed over the quarter as higher volatility returned, providing minimal results following strong performance in the first half of the year. Though the broader U.S. market was down slightly (Russell 3000), the S&P 500 finished higher despite concerns about rising inflation.
Insight
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
We’re here to help you break through complex challenges and achieve next-level success.